Polymorphisms in the genes of citohrom oxidase P450 2D6 (CYP2D6), paraoxonase 1 (PON1) and apolipoproteine E (APOE) as risk factors for Parkinson's disease
Open Access
- 1 January 2007
- journal article
- abstracts
- Published by National Library of Serbia in Vojnosanitetski Pregled
- Vol. 64 (1) , 25-30
- https://doi.org/10.2298/vsp0701025d
Abstract
Background/Aim. The presence of Parkinson's disease (PD) among the members of a family is a clear indication of the significance of genetics in its development. In spite of that, the majority of patients with PD shows a sporadic form of the disease induced as a result of interaction of both environmental and genetic factors. The aim of this study was to examine the effects of polymorphisms in the genes of cytohrome P450 2D6(CYP2D6), paraoxonase 1 (PON 1) and apolipoprotein E (APOE), as risk factors for PD. Methods. We examined 106 patients with PD (65 men and 41 women) and 75 ethnically matched control subjects. The mean age at onset of PD in the patients was 46.9?9.4 years (ranging from 30 to 70 years). Genotyping was performed using standard PCR amplification and restriction endonuclease digestion protocols described for known polymorphism in the candidate genes under study. Results. The genotype A/A polymorphisms 2D6* gene of CYP2D6 and genotype M/M polymorphisms L54M gene of PON1 were significantly more frequent in the patients with PD than in the control group. The patients with genotypes A/A and M/M had 3.4 and 3.2 higher risk of PD, respectively than the control group (p = 0.01). The relation between genotypes A/A gene of CYP2D6 and M/M gene of PON1 was modified by the age at onset. The genotypes were associated with early onset of PD (p = 0.001, p = 0.004). The carriers of the A and M alleles in homozygote had 2.4 and 4.2 years respectively earlier onset of PD than carriers of other genotypes with these polymorphisms. The frequency allele ?4 gene of APOE was higher in the PD patients with early onset (20%) than in PD with later onset (7.4%), while the genotype ?3/?3 was associated with PD late onset (p = 0.024). Combined genotype I (carriers of the two risk allels in homozygote and one alleles risk in heterozygote) and combined genotype II (carriers of the three alleles risk in homozygote) caused early PD. Combined genotype II was detected in 12.7% of the patients in the group of early onset, and in 2.4% of the patients with the onset after 45 years. Conclusion. The results of our study suggest that the genotypes A/A and M/M genes of CYP2D6 and PON1, and allele ?4 gene are an important risk for the development of PD, causing its early onset. The cumulative effects of the risk genes cause an early onset of PD.Keywords
This publication has 13 references indexed in Scilit:
- Further evidence for an association of the Paraoxonase 1 (PON1) Met‐54 allele with Parkinson's diseaseMovement Disorders, 2002
- Paraoxonase 1 Met–Leu 54 polymorphism is associated with Parkinson’s diseaseJournal of the Neurological Sciences, 2001
- Parkinson Disease in TwinsAn Etiologic StudyJAMA, 1999
- Apolipoprotein E, a Gene with Complex Biological Interactions in the Aging BrainNeurobiology of Disease, 1997
- Metabolism of MPTP by cytochrome P4502D6 and the demonstration of 2D6 m RNA in human foetal and adult brain by in situ hybridizationXenobiotica, 1997
- Nomenclature for human CYP2D6 allelesPharmacogenetics, 1996
- Genetic Dissection of Complex TraitsScience, 1994
- Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's diseaseAmerican Journal of Medical Genetics, 1993
- Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's diseaseThe Lancet, 1992
- Mutant debrisoquine hydroxylation genes in Parkinson's diseaseThe Lancet, 1992